Source: The Insides Company Limited
Date: Wednesday, 11 January 2023
Companies: The Insides Company Limited
Chyme reinfusion therapy has now been included in the New Zealand National Failure & Rehabilitation Service (NZ NIFRS) clinical guidelines.
The NZ NIFRS clinical guidelines for chyme reinfusion links to The Insides Company Training Hub where available content includes guidance around establishing, maintaining and monitoring chyme reinfusion therapy using The Insides System, an automated chyme reinfusion solution for reinfusing the intestinal losses of patients with a high-output fistula or enterostomy.
Chyme reinfusion is an established technique recommended by the international societies ASPEN and ESPEN for the nutrition of Type 2 Intestinal Failure patients (Klek et al., 2016).
Chyme reinfusion enables:
Clinicians will be able to gain access to the chyme reinfusion clinical guidelines via the link below.
About The Insides Company
The Insides Company Limited is a leading provider of automated chyme reinfusion solutions for the therapeutic treatment of intestinal failure that has resulted from either a high-output enterocutaneous fistula or enterostomy.
The Insides Company
Garth Sutherland, CEO
Phone: +64 9 887 9309